Protocol of notable-HCC: a phase Ib study of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma

Bo Zhang; Jinbo Yue; Xuetao Shi; Kai Cui; Lei Li; Chengsheng Zhang; Pengfei Sun; Jingtao Zhong; Zhongchao Li; Lei Zhao

doi:10.1136/bmjopen-2022-060955

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

For authors

About

Browse by collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

Gastroenterology and hepatology

Protocol

Protocol of notable-HCC: a phase Ib study of neoadjuvant tislelizumab with stereotactic body radiotherapy in patients with resectable hepatocellular carcinoma

Online download statistics by month:

Online download statistics by month: September 2022 to March 2023

	Abstract	Full	Pdf
Sep 2022	785	785	100
Oct 2022	433	432	61
Nov 2022	316	314	36
Dec 2022	348	346	23
Jan 2023	299	301	17
Feb 2023	194	192	22
Mar 2023	39	37	25
Total	2414	2407	284

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: September 2022 to March 2023

Read the full text or download the PDF:

Log in using your username and password